Shinji Nakamichi

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Epidermal Growth Factor Receptor

Small Cell Lung Cancer

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

OncoTargets and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Naomi Onda, Shinji Nakamichi, Mariko Hirao, Kuniko Matsuda, Masaru Matsumoto, Akihiko Miyanaga, Rintaro Noro, Akihiko Gemma, Masahiro Seike
Afatinib plus PEM and CBDCA overcome osimertinib resistance in EGFR-mutated NSCLC with high thrombospondin-1 expression. Cancer science 115 (8) (2024)
Naomi Onda, Shinji Nakamichi, Mariko Hirao, Kuniko Matsuda, Masaru Matsumoto, Akihiko Miyanaga, Rintaro Noro, Akihiko Gemma, Masahiro Seike
Afatinib plus PEM and CBDCA overcome osimertinib resistance in EGFR-mutated NSCLC with high thrombospondin-1 expression. Cancer science 115 (8) (2024)
Shinji Nakamichi, Kaoru Kubota, Toshihiro Misumi, Tetsuro Kondo, Shuji Murakami, Yoshimasa Shiraishi, Hisao Imai, Daijiro Harada, Kazutoshi Isobe, Hidetoshi Itani, Saori Takata, Kazuyoshi Kuwano, Yuki Misumi, Satoshi Ikeda, Tetsuhiko Asao, Naoki Furuya, Shinobu Hosokawa, Yumiko Kobayashi, Yuichi Takiguchi, Hiroaki Okamoto
Phase II Study of Durvalumab Immediately after Completion of Chemoradiotherapy in Unresectable Stage III Non-small Cell Lung Cancer: TORG1937 (DATE Study). Clinical cancer research : an official journal of the American Association for Cancer Research 30 (6) (2024)
Shinji Nakamichi, Kaoru Kubota, Toshihiro Misumi, Tetsuro Kondo, Shuji Murakami, Yoshimasa Shiraishi, Hisao Imai, Daijiro Harada, Kazutoshi Isobe, Hidetoshi Itani, Saori Takata, Kazuyoshi Kuwano, Yuki Misumi, Satoshi Ikeda, Tetsuhiko Asao, Naoki Furuya, Shinobu Hosokawa, Yumiko Kobayashi, Yuichi Takiguchi, Hiroaki Okamoto
Phase II study of durvalumab immediately after completion of chemoradiotherapy in unresectable stage III non-small-cell lung cancer: TORG1937 (DATE study). Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Naomi Onda, Shinji Nakamichi, Mariko Hirao, Kuniko Matsuda, Masaru Matsumoto, Akihiko Miyanaga, Rintaro Noro, Akihiko Gemma, Masahiro Seike
Afatinib plus PEM and CBDCA overcome osimertinib resistance in EGFR-mutated NSCLC with high thrombospondin-1 expression. Cancer science (2024)
Naomi Onda, Shinji Nakamichi, Mariko Hirao, Kuniko Matsuda, Masaru Matsumoto, Akihiko Miyanaga, Rintaro Noro, Akihiko Gemma, Masahiro Seike
Afatinib plus PEM and CBDCA overcome osimertinib resistance in EGFR-mutated NSCLC with high thrombospondin-1 expression. Cancer science 115 (8) (2024)
Anna Hayashi, Shinji Nakamichi, Yukako Nakayama, Atsuhiro Nagano, Erika Mikami, Natsuki Takano, Takehiro Tozuka, Masaru Matsumoto, Akihiko Miyanaga, Rintaro Noro, Yasuhiro Terasaki, Kaoru Kubota, Masahiro Seike, Akihiko Gemma
Successful Treatment with Short-Term Steroid Against Severe Hepatitis Confirmed by Liver Biopsy in a Patient with Advanced Squamous-Cell Lung Cancer Receiving a Combination of Pembrolizumab, Carboplatin, and Nab-Paclitaxel: A Case Report. OncoTargets and therapy 15 (2022)